108 related articles for article (PubMed ID: 2552305)
1. Production of inositol-phospholipid-derived second messengers in a rat natural killer cell line exposed to susceptible tumor targets.
Atkinson EA; Gerrard JM; Hildes GE; Greenberg AH
Nat Immun Cell Growth Regul; 1989; 8(4):223-30. PubMed ID: 2552305
[TBL] [Abstract][Full Text] [Related]
2. Studies of the mechanism of natural killer (NK) degranulation and cytotoxicity.
Atkinson EA; Gerrard JM; Hildes GE; Greenberg AH
J Leukoc Biol; 1990 Jan; 47(1):39-48. PubMed ID: 2152939
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP.
Windebank KP; Abraham RT; Powis G; Olsen RA; Barna TJ; Leibson PJ
J Immunol; 1988 Dec; 141(11):3951-7. PubMed ID: 2846696
[TBL] [Abstract][Full Text] [Related]
4. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.
Ryan JC; Niemi EC; Goldfien RD; Hiserodt JC; Seaman WE
J Immunol; 1991 Nov; 147(9):3244-50. PubMed ID: 1919012
[TBL] [Abstract][Full Text] [Related]
5. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
Kaufman DS; Schoon RA; Leibson PJ
J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
[TBL] [Abstract][Full Text] [Related]
6. Granulocytic differentiation of HL60 human promyelocytic leukemia cells is preceded by a reduction in levels of inositol lipid-derived second messengers.
Porfiri E; Hoffbrand AV; Wickremasinghe RG
Exp Hematol; 1988 Aug; 16(7):641-6. PubMed ID: 2839354
[TBL] [Abstract][Full Text] [Related]
7. A central role for phosphoinositide hydrolysis in activating the lytic mechanism of human natural killer cells.
Chow SC; Jondal M
Immunology; 1990 May; 70(1):106-10. PubMed ID: 2162323
[TBL] [Abstract][Full Text] [Related]
8. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
Roozemond RC; van der Geer P; Bonavida B
J Immunol; 1986 May; 136(10):3921-9. PubMed ID: 3701064
[TBL] [Abstract][Full Text] [Related]
9. Regulation of gene expression by the intracellular second messengers IP3 and diacylglycerol.
Kimmel AR; Eisen M
Dev Genet; 1988; 9(4-5):351-8. PubMed ID: 3266590
[TBL] [Abstract][Full Text] [Related]
10. Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing.
Giardina SL; Anderson SK; Sayers TJ; Chambers WH; Palumbo GA; Young HA; Ortaldo JR
J Immunol; 1995 Jan; 154(1):80-7. PubMed ID: 7995961
[TBL] [Abstract][Full Text] [Related]
11. Activation of inositol cycle in large granular lymphocyte leukemia RNK following contact with an NK-sensitive tumor.
Gerrard JM; Hildes E; Atkinson EA; Greenberg AH
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():573-6. PubMed ID: 2821768
[No Abstract] [Full Text] [Related]
12. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
[TBL] [Abstract][Full Text] [Related]
13. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
[TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
Wright SC; Bonavida B
J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
[TBL] [Abstract][Full Text] [Related]
15. CD45-negative mutants of a rat natural killer cell line fail to lyse tumor target cells.
Bell GM; Dethloff GM; Imboden JB
J Immunol; 1993 Oct; 151(7):3646-53. PubMed ID: 8104222
[TBL] [Abstract][Full Text] [Related]
16. Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat.
Reynolds CW; Bere EW; Ward JM
J Immunol; 1984 Jan; 132(1):534-40. PubMed ID: 6197459
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
18. Differential effect on inositol-phospholipid hydrolysis, cytosolic-free Ca2+ concentration, protein kinase C activity and protein phosphorylation of 1-oleoyl-2-acetyl-sn-glycerol growth-stimulated ascites tumor cells.
Seibicke S; Strosznajder JB; Haeffner EW
Eur J Cell Biol; 1988 Aug; 46(3):403-10. PubMed ID: 2846301
[TBL] [Abstract][Full Text] [Related]
19. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
20. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]